← Eichor
Study identifier: NCT06430762 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Therapeutic Exposures and Risk Factors in MRONJ

Condition: Medication-Related Osteonecrosis of Jaw  ·  Sponsor: Marmara University

PhaseN/A
Planned participants250
Who can joinAll sexes, 18 Years to 110 Years
Healthy volunteersYes

About this study

This study focuses on patients who have developed a condition called medication-related osteonecrosis of the jaw (MRONJ), which can occur after using certain medications. The purpose is to closely monitor these patients over time to better understand how they are diagnosed, treated, and followed up. By doing this, researchers hope to uncover how different factors such as a patient's background, lifestyle, and other health conditions might influence their recovery and overall quality of life.

This description comes directly from the study's public registry record.

Talk to the study team

Ferit Bayram, PhD  ·  00902167775000  ·  ferit.bayram@marmara.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Marmara University School of DentistryIstanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06430762